COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes.
作者信息
Hahn Erin E, Eng Sarah, Chen Aiyu, Haupt Eric C, Goodall Shannon, Munoz-Plaza Corrine E, Nguyen Huong Q, Gould Michael K, Ganz Patricia A, Shen Ernest
机构信息
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
出版信息
JAMA Oncol. 2025 Jul 17. doi: 10.1001/jamaoncol.2025.1991.
Abstract
摘要
相似文献
1
COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes.新冠疫情与乳腺癌治疗后监测及预后
JAMA Oncol. 2025 Jul 17. doi: 10.1001/jamaoncol.2025.1991.
2
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study.数字病理学与光学显微镜检查在组织病理学切片诊断中的内部及相互间差异：双盲交叉对比研究
Health Technol Assess. 2025 Jul;29(30):1-75. doi: 10.3310/SPLK4325.
3
Telehealth and Health Care Contact Days Among Patients With Advanced Cancer After COVID-19.COVID-19 后晚期癌症患者的远程医疗与医疗保健接触天数
JAMA Netw Open. 2025 Jun 2;8(6):e2516762. doi: 10.1001/jamanetworkopen.2025.16762.
4
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.学校为遏制新冠疫情而采取的措施所产生的意外后果：一项范围综述。
Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD015397. doi: 10.1002/14651858.CD015397.pub2.
7
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中，在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值：对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
8
The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment of Breast Cancer at a Community Hospital.新冠疫情对一家社区医院乳腺癌诊断与治疗的影响
Clin Breast Cancer. 2025 Jul;25(5):e545-e554. doi: 10.1016/j.clbc.2025.02.005. Epub 2025 Feb 14.
9
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.生物标志物作为即时检测手段，指导初级保健中急性呼吸道感染患者使用抗生素的处方。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.
10
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
本文引用的文献
1
A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.COVID-19 大流行对乳腺癌筛查和诊断影响的系统评价。
Breast. 2023 Feb;67:78-88. doi: 10.1016/j.breast.2023.01.001. Epub 2023 Jan 5.
2
Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic.COVID-19 大流行期间 32 家社区卫生中心乳腺癌筛查率的变化。
Cancer. 2021 Dec 1;127(23):4512-4515. doi: 10.1002/cncr.33859. Epub 2021 Aug 26.
3
Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.美国癌症筛查不足与新冠疫情的关联。
JAMA Oncol. 2021 Jun 1;7(6):878-884. doi: 10.1001/jamaoncol.2021.0884.
4
Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.2019 冠状病毒病对乳腺癌筛查和诊断程序的人群影响。
Cancer. 2021 Jun 15;127(12):2111-2121. doi: 10.1002/cncr.33460. Epub 2021 Feb 26.
Zotero 插件